Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib

AIM: We aimed to provide real-life data on the outcomes of metastatic renal cell carcinoma (mRCC) patients treated with everolimus as second-line treatment after failure of first-line pazopanib. PATIENTS AND METHODS: Data from the medical charts of mRCC patients from 8 centers in Greece and Spain we...

Descripción completa

Detalles Bibliográficos
Autores principales: Koutsoukos, Konstantinos, Bamias, Aristotelis, Tzannis, Kimon, Espinosa Montaño, Marta, Bozionelou, Vasiliki, Christodoulou, Christos, Stefanou, Dimitra, Kalofonos, Haralabos, Duran, Ignacio, Papazisis, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640393/
https://www.ncbi.nlm.nih.gov/pubmed/29062235
http://dx.doi.org/10.2147/OTT.S141260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640393/
https://www.ncbi.nlm.nih.gov/pubmed/29062235
http://dx.doi.org/10.2147/OTT.S141260

Ejemplares similares